Cargando…
COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
An acute respiratory disorder (COVID-19) that accelerated across the globe has been found to be caused by a novel strain of coronaviruses (SARS-CoV-2). The absence of a specific antiviral drug or vaccination has promoted the development of immediate therapeutic responses against SARS-CoV-2. As incre...
Autores principales: | Seth, Sanchit, Batra, Jyotsna, Srinivasan, Srilakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581869/ https://www.ncbi.nlm.nih.gov/pubmed/33195400 http://dx.doi.org/10.3389/fmolb.2020.00215 |
Ejemplares similares
-
Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
por: Rahbar Saadat, Yalda, et al.
Publicado: (2021) -
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
por: Cui, Wen, et al.
Publicado: (2020) -
Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors
por: Narayanan, Krishna K., et al.
Publicado: (2021) -
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021) -
Host cell stress response as a predictor of COVID-19 infectivity and disease progression
por: Caillet, Celine, et al.
Publicado: (2022)